ANI Pharmaceuticals, Inc. (ANIP)
78.36
-1.78
(-2.22%)
USD |
NASDAQ |
Apr 10, 16:00
78.32
-0.04
(-0.05%)
After-Hours: 20:00
ANI Pharmaceuticals Market Cap : 1.783B for April 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 3.397B |
| Catalyst Pharmaceuticals, Inc. | 3.046B |
| Indivior Pharmaceuticals, Inc. | 3.724B |
| Replimune Group, Inc. | 393.05M |
| ADMA Biologics, Inc. | 2.310B |
Market Cap Related Metrics
| PE Ratio | 23.38 |
| PS Ratio | 1.846 |
| Price to Book Value | 3.297 |
| Price to Free Cash Flow | 10.80 |
| Price | 78.36 |
| Earnings Yield | 4.28% |
| Operating PE Ratio | 20.07 |
| Normalized PE Ratio | 34.95 |